We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved elafibranor (Iqirvo) to treat adult patients with a rare type of liver disease known as primary biliary cholangitis (PBC).
Measures biomarkers of lipid metabolism in response to a marginal zinc depletion, repletion and supplementation in healthy males
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
Information from the National Health Service on conditions, treatments, local services and healthy living
Evidence and information to help healthcare professionals raise awareness of risk factors for liver disease.
A guide to support the implementation of NICE Guidance (CG71) on the identification and management of familial hypercholesterolaemia.
A professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation, high blood pressure and high cholesterol
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).